See up to 3 months of CYRX. The 7-day demo opens the 1M and 3M ranges and puts CYRX on your watchlist.
Start 7-day demoLatest CYRX insider trades
About Cryoport, Inc. (CYRX)
The SEC lists Cryoport, Inc. under CIK 0001124524, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
CYRX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 28,800 | $429K |
CYRX insider transactions (Form 4)
8542 Form 4 filings on record, the earliest from Nov 20, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Common Stock | 28,800 | $14.91 footnote F2 | $429K | ||
| ||||||
| Edward J. Zecchini - Officer | Option exercise | Common Stock | 1,400 | $4.80 | $7K | |
| Edward J. Zecchini - Officer | Option exercise | Common Stock | 33,600 | $4.80 | $161K | |
| Edward J. Zecchini - Officer | Open-market sale | Common Stock | 1,400 | $15.23 footnote F1 | $21K | |
| Edward J. Zecchini - Officer | Open-market sale | Common Stock | 33,600 | $14.47 footnote F2 | $486K | |
| Edward J. Zecchini - Officer | Option exercise | Stock Option (right to buy) | 1,400 | $0.00 | - | |
| Edward J. Zecchini - Officer | Option exercise | Stock Option (right to buy) | 33,600 | $0.00 | - | |
| ||||||
| Linda Baddour - Director | Grant or award | Common Stock | 10,350 | $0.00 footnote F1 | - | |
| Linda Baddour - Director | Grant or award | Option (Right to Buy Common Stock) | 16,077 | $0.00 | - | |
| ||||||
| Robert Stefanovich - Officer | Open-market sale | Common Stock | 169,427 | $16.27 footnote F1 | $2.76M | |
| ||||||
| Daniel M. Hancock - Director | Grant or award | Common Stock | 10,350 | $0.00 footnote F1 | - | |
| Daniel M. Hancock - Director | Grant or award | Option (Right to Buy Common Stock) | 16,077 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock | 10,350 | $0.00 footnote F1 | - | ||
| Grant or award | Option (Right to Buy Common Stock) | 16,077 | $0.00 | - | ||
| ||||||
| Ramkumar Mandalam - Director | Grant or award | Common Stock | 10,350 | $0.00 footnote F1 | - | |
| Ramkumar Mandalam - Director | Open-market sale | Common Stock | 23,214 | $15.44 footnote F2 | $358K | |
| Ramkumar Mandalam - Director | Grant or award | Option (Right to Buy Common Stock) | 16,077 | $0.00 | - | |
| ||||||
| Option exercise | Common Stock | 104,007 | $1.87 | $194K | ||
| Option exercise | Options to purchase common stock | 104,007 | $0.00 | - | ||
| Option exercise | Common Stock | 50,000 | $1.87 | $94K | ||
| Option exercise | Options to purchase common stock | 50,000 | $0.00 | - | ||
| Robert Stefanovich - Officer | Open-market sale | Common Stock | 1,094 | $8.18 | $9K | |
| Option exercise | Common Stock | 25,000 | $1.87 | $47K | ||
| Open-market sale | Common Stock | 2,894 | $8.18 | $24K | ||
| Option exercise | Options to purchase common stock | 25,000 | $0.00 | - | ||
| Mark W. Sawicki - Officer | Open-market sale | Common Stock | 1,341 | $8.18 | $11K | |
| Edward J. Zecchini - Officer | Grant or award | Common Stock | 21,322 | $0.00 footnote F1 | - | |
| Edward J. Zecchini - Officer | Open-market sale | Common Stock | 2,014 | $8.00 | $16K | |
| Edward J. Zecchini - Officer | Grant or award | Stock Option (right to buy) | 63,965 | $0.00 | - | |
| ||||||
| Open-market sale | Common Stock | 7,918 | $8.00 | $63K | ||
| Grant or award | Stock Option (right to buy) | 492,901 | $0.00 | - | ||
| Mark W. Sawicki - Officer | Grant or award | Common Stock | 22,845 | $0.00 footnote F1 | - | |
| Mark W. Sawicki - Officer | Open-market sale | Common Stock | 3,235 | $8.00 | $26K | |
| Mark W. Sawicki - Officer | Grant or award | Stock Option (right to buy) | 68,534 | $0.00 | - | |
| ||||||
| Robert Stefanovich - Officer | Option exercise | Common Stock | 87,188 | $1.87 | $163K | |
| Robert Stefanovich - Officer | Open-market sale | Common Stock | 38,700 | $7.76 footnote F2 | $300K | |
| Robert Stefanovich - Officer | Grant or award | Common Stock | 27,413 | $0.00 footnote F3 | - | |
| Robert Stefanovich - Officer | Open-market sale | Common Stock | 2,743 | $8.00 | $22K | |
| Robert Stefanovich - Officer | Option exercise | Options to purchase common stock | 87,188 | $0.00 | - | |
| Robert Stefanovich - Officer | Grant or award | Stock Option (right to buy) | 82,240 | $0.00 | - | |
| ||||||
| Option exercise | Common Stock | 50,000 | $2.66 | $133K | ||
| Open-market sale | Common Stock | 25,000 | $9.71 | $243K | ||
| Option exercise | Stock Option (right to buy) | 50,000 | $0.00 | - | ||
| Open-market sale | Common Stock | 5,000 | $8.60 | $43K | ||
| Robert Stefanovich - Officer | Option exercise | Common Stock | 26,164 | $3.07 | $80K | |
| Robert Stefanovich - Officer | Open-market sale | Common Stock | 9,300 | $8.67 | $81K | |
| Robert Stefanovich - Officer | Option exercise | Options to purchase common stock | 26,164 | $0.00 | - | |
| Option exercise | Common Stock | 25,000 | $5.00 | $125K | ||
| Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | ||
| Option exercise | Common Stock | 25,000 | $5.00 | $125K | ||
| Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | ||
| Option exercise | Common Stock | 25,000 | $5.00 | $125K | ||
| Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | ||
| Ramkumar Mandalam - Director | Option exercise | Common Stock | 60,000 | $3.07 | $184K | |
| Ramkumar Mandalam - Director | Open-market sale | Common Stock | 40,728 | $7.24 | $295K | |
| Ramkumar Mandalam - Director | Option exercise | Stock Option (right to buy) | 60,000 | $0.00 | - | |
| Option exercise | Common Stock | 25,000 | $5.00 | $125K | ||
| Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | ||
| Option exercise | Common Stock | 25,000 | $5.00 | $125K | ||
| Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | ||
| Option exercise | Common Stock | 16,344 | $5.00 | $82K | ||
| Open-market sale | Common Stock | 16,344 | $7.06 | $115K | ||
| Option exercise | Common Stock | 25,000 | $5.00 | $125K | ||
| Option exercise | Stock Option (right to buy) | 16,344 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | ||
| Ramkumar Mandalam - Director | Option exercise | Common Stock | 20,000 | $3.07 | $61K | |
| Ramkumar Mandalam - Director | Open-market sale | Common Stock | 13,321 | $7.02 | $93K | |
| Ramkumar Mandalam - Director | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Option exercise | Common Stock | 50,000 | $5.00 | $250K | ||
| Option exercise | Common Stock | 151,304 | $5.00 | $757K | ||
| Open-market sale | Common Stock | 151,304 | $6.81 | $1.03M | ||
| Option exercise | Common Stock | 119,281 | $5.00 | $596K | ||
| Open-market sale | Common Stock | 119,281 | $6.81 | $813K | ||
| Option exercise | Common Stock | 69,135 | $5.00 | $346K | ||
| Open-market sale | Common Stock | 69,135 | $6.47 | $448K | ||
| Option exercise | Stock Option (right to buy) | 50,000 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 151,304 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 119,281 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 69,135 | $0.00 | - | ||
| Ramkumar Mandalam - Director | Open-market sale | Common Stock | 8,193 | $7.06 | $58K | |
| Ramkumar Mandalam - Director | Open-market sale | Common Stock | 1,895 | $7.01 | $13K | |
| Ramkumar Mandalam - Director | Open-market sale | Common Stock | 624 | $6.80 | $4K | |
| Edward J. Zecchini - Officer | Option exercise | Common Stock | 75,000 | $3.07 | $230K | |
| Edward J. Zecchini - Officer | Open-market sale | Common Stock | 51,500 | $6.85 | $353K | |
| Edward J. Zecchini - Officer | Option exercise | Stock Option (right to buy) | 75,000 | $0.00 | - | |
Recent CYRX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JERRELL W SHELTON | Director, Officer | 28,800 | $427K | View on EDGAR | |
| - | - | - | - |
CYRX insider trading FAQ
What is the latest insider trade for CYRX?
Cryoport, Inc. (CYRX) had 1 insider filing in the last 90 days, with the most recent on 2026-08-11. The full record for CYRX runs to 42 Form 4 filings, the earliest from 2024-11-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CYRX stock?
No insider purchases of CYRX were filed in the last 90 days.
How many insiders are selling CYRX stock?
1 insider sale of CYRX was filed in the last 90 days, totaling $429K.
Where can I see CYRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CYRX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jerrell Shelton view on EDGAR
- - Edward J. Zecchini view on EDGAR
- - Linda Baddour view on EDGAR
- - Robert Stefanovich view on EDGAR
- - Daniel M. Hancock view on EDGAR
- - Robert J. Hariri view on EDGAR
- - Ramkumar Mandalam view on EDGAR
- - Jerrell Shelton view on EDGAR
- - Jerrell Shelton view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CYRX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CYRX with a 7-day demo
- CYRX on your watchlist
- Every CYRX Form 4 filing on record
- Up to 3 months of CYRX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive